SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-18-018379
Filing Date
2018-04-12
Accepted
2018-04-12 16:52:32
Documents
1
Effectiveness Date
2018-04-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12254
  Complete submission text file 0001140361-18-018379.txt   13582
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-310059 | Film No.: 18752550
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10